NDC 72196-0204-1

This exact product or package identity exists in FDA auxiliary data but is not present in the current primary NDC product table. The package identity is preserved; status rows are reported source observations, not medical conclusions.

Requested NDC: 72196-0204-1
Product root: 72196-0204
Identity scope: Package
Primary current NDC product row: Not present

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
compounder	package	72196-0204	72196-0204-1	COMPOUNDER	Outsourcing facility compounded drug report	2024-2	2026-09-18
compounder	package	72196-0204	72196-0204-1	COMPOUNDER	Outsourcing facility compounded drug report	2024-2	2026-10-15
compounder	package	72196-0204	72196-0204-1	COMPOUNDER	Outsourcing facility compounded drug report	2023-2	2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 5 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Reporting period, Snapshot table
Captured / source date	Reporting period	Snapshot	Source SHA-256
2025-12-16 00:49 UTC · source 2025-09-25	2024-2	`3f6f48d8db7b…`	`6316a3eebc6a…`
2025-12-16 00:49 UTC · source 2025-09-25	2023-2	`3f6f48d8db7b…`	`6316a3eebc6a…`
2025-08-27 00:00 UTC · source 2025-08-20	2024-2	`af8e9b524e63…`	`ca326a94a5e9…`
2025-08-27 00:00 UTC · source 2025-08-20	2023-2	`af8e9b524e63…`	`ca326a94a5e9…`
2025-01-13 04:20 UTC · source 2024-11-20	2023-2	`85f958c8d153…`	`997044a9741e…`

Compounder NDC reports#

Browse the complete compounder directory for this NDC · Browse every current compounder row in the unified auxiliary catalog · browse compounder source captures and parsed snapshots.

Establishment, FEI, Product NDC table
Establishment	Product NDC	Package NDC	Product	Active ingredients	Reporting period	Normalization
"Central Admixture Pharmacy Services, Inc.(080955366)"	72196-0204	72196-0204-1	Potassium Chloride; Sodium Bicarbonate; Calcium Chloride; Sodium Chloride; Magnesium Sulfate Heptahydrate	106 meq/1000 mL; 3.864 g/1000 mL; 2.176 meq/1000 mL; 100 meq/1000 mL; 29.232 meq/1000 mL	2024-2	valid
Central Admixture Pharmacy Services, Inc.	72196-0204	72196-0204-1	Modified St. Thomas High K (106 mEq) High Sodium Bicarbonate 1000 mL Bag	106 meq/1000 mL; 3.864 g/1000 mL; 2.176 meq/1000 mL; 100 meq/1000 mL; 29.232 meq/1000 mL	2024-2	valid
"Central Admixture Pharmacy Services, Inc.(080955366)"	72196-0204	72196-0204-1	Potassium Chloride; Sodium Bicarbonate; Calcium Chloride; Sodium Chloride; Magnesium Sulfate Heptahydrate	106 meq/1000 mL; 3.864 g/1000 mL; 2.176 meq/1000 mL; 100 meq/1000 mL; 29.232 meq/1000 mL	2023-2	valid

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.